NEW YORK (GenomeWeb News) — Shares in Tripos were up 21 percent, or $.13, at $.74 in mid-afternoon trading after the company said it has found a buyer for its Discovery Informatics business.
As GenomeWeb News reported this morning, Tripos said it will sell the division to Venture for $26.5 million in cash and it said it expects to distribute between $6 million and $12 million to its shareholders when the sale closes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.